Liver Transplant News and Research

RSS
When a patient presents with end stage liver disease or liver failure he or she may be considered for a liver transplantation. The first step in this is often a rigorous assessment and being placed on a waiting list.
Livers have a cumulative age of at least 100 years, researchers find

Livers have a cumulative age of at least 100 years, researchers find

Study opens up new approaches for treating fatty liver disease

Study opens up new approaches for treating fatty liver disease

Chronic liver disease in COVID-19 patients

Chronic liver disease in COVID-19 patients

Study offers support for increasing the use of living donor liver transplantation in Western countries

Study offers support for increasing the use of living donor liver transplantation in Western countries

Embedded bias: How medical records sow discrimination

Embedded bias: How medical records sow discrimination

A triad of obesity, heavy alcohol use, and coagulopathy predicts return to OR after liver transplant

A triad of obesity, heavy alcohol use, and coagulopathy predicts return to OR after liver transplant

Machine learning models can predict posttreatment recurrence in patients with early-stage hepatocellular carcinoma

Machine learning models can predict posttreatment recurrence in patients with early-stage hepatocellular carcinoma

UW cardiologists employ catheter-delivered device to retrieve a benign tumor from the heart

UW cardiologists employ catheter-delivered device to retrieve a benign tumor from the heart

Extracellular vesicle-based surface protein assay likely to lead to a better way to detect early-stage hepatocellular carcinoma

Extracellular vesicle-based surface protein assay likely to lead to a better way to detect early-stage hepatocellular carcinoma

Transplant remains the standard of care for liver cancer patients, regardless of age

Transplant remains the standard of care for liver cancer patients, regardless of age

SLU and industry partners report the first effective drug to treat rare, genetic liver disease

SLU and industry partners report the first effective drug to treat rare, genetic liver disease

Researchers discover the first effective drug to treat rare, genetic liver disease

Researchers discover the first effective drug to treat rare, genetic liver disease

Widely used hospital gowns show signs of exposing workers to infection

Widely used hospital gowns show signs of exposing workers to infection

Studies discover multiple gene variants that contribute to the risk  and severity of NAFLD in children

Studies discover multiple gene variants that contribute to the risk and severity of NAFLD in children

Increasing growth hormone levels can improve liver health in patients with NAFLD

Increasing growth hormone levels can improve liver health in patients with NAFLD

Study outlines risk factors for autoimmune hepatitis after liver transplant

Study outlines risk factors for autoimmune hepatitis after liver transplant

Study finds significant decline in attending adult health care appointments among pediatric transplant patients

Study finds significant decline in attending adult health care appointments among pediatric transplant patients

Siemens Healthineers launches Enhanced Liver Fibrosis (ELF) Test in the U.S.

Siemens Healthineers launches Enhanced Liver Fibrosis (ELF) Test in the U.S.

SLU physician-scientist receives NIH funding for Short Bowel Syndrome research

SLU physician-scientist receives NIH funding for Short Bowel Syndrome research

Transformational $104 million gift will help VCU to expand treatment options for liver diseases

Transformational $104 million gift will help VCU to expand treatment options for liver diseases